Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
1.
Sci Rep ; 10(1): 1503, 2020 01 30.
Article in English | MEDLINE | ID: mdl-32001774

ABSTRACT

We report a detailed study of a cohort of sporadic Creutzfeldt-Jakob disease (sCJD) VV1-2 type-mixed cases (valine homozygosity at codon 129 of the prion protein, PrP, gene harboring disease-related PrP, PrPD, types 1 and 2). Overall, sCJDVV1-2 subjects showed mixed clinical and histopathological features, which often correlated with the relative amounts of the corresponding PrPD type. However, type-specific phenotypic characteristics were only detected when the amount of the corresponding PrPD type exceeded 20-25%. Overall, original features of types 1 (T1) and 2 (T2) in sCJDVV1 and -VV2, including rostrocaudal relative distribution and conformational indicators, were maintained in sCJDVV1-2 except for one of the two components of T1 identified by electrophoretic mobility as T121. The T121 conformational characteristics shifted in the presence of T2, inferring a conformational effect of PrPD T2 on T121. The prevalence of sCJDVV1-2 was 23% or 57% of all sCJDVV cases, depending on whether standard or highly sensitive type-detecting procedures were adopted. This study, together with previous data from sCJDMM1-2 (methionine homozygosity at PrP gene codon 129) establishes the type-mixed sCJD variants as an important component of sCJD, which cannot be identified with current non-tissue based diagnostic tests of prion disease.


Subject(s)
Creutzfeldt-Jakob Syndrome/genetics , PrPSc Proteins/genetics , Adult , Aged , Aged, 80 and over , Brain/metabolism , Brain/pathology , Cohort Studies , Creutzfeldt-Jakob Syndrome/metabolism , Creutzfeldt-Jakob Syndrome/pathology , Female , Genetic Association Studies , Humans , Male , Middle Aged , PrPSc Proteins/chemistry , PrPSc Proteins/classification , Protein Conformation , Protein Stability , Tissue Distribution , Valine/chemistry , Valine/genetics
2.
Methods Mol Biol ; 1658: 263-283, 2017.
Article in English | MEDLINE | ID: mdl-28861795

ABSTRACT

Transmissible spongiform encephalopathies (TSE) or prion diseases exhibit strain variation, a phenomenon that has been studied extensively in mouse bioassays. Despite the introduction of many rapid in vitro systems, bioassays remain a key tool in defining prion strains and their ability to transmit disease in vivo. Prion strains can be characterized by a range of phenotypic characteristics such as incubation period, vacuolar pathology, and distribution of the abnormal form of PrP following experimental transmission of the agent into a panel of mice (transgenic or wild type). Interpretation of these characteristics requires considerable experience and an understanding of the procedures used to define them. This chapter reviews the techniques used in strain typing of prion diseases from inoculum preparation and pathological studies to data interpretation alongside an extensive troubleshooting guide.


Subject(s)
Biological Assay , Brain/pathology , PrPC Proteins/chemistry , PrPSc Proteins/chemistry , Prion Diseases/pathology , Animals , Brain/metabolism , Disease Models, Animal , Gait , Gene Expression , Histocytochemistry/methods , Mice , Mice, Transgenic , Microtomy/methods , Phenotype , PrPC Proteins/classification , PrPC Proteins/genetics , PrPC Proteins/metabolism , PrPSc Proteins/classification , PrPSc Proteins/genetics , PrPSc Proteins/metabolism , Prion Diseases/genetics , Prion Diseases/metabolism , Species Specificity , Tissue Embedding/methods , Tissue Fixation/methods
3.
PLoS One ; 8(3): e57851, 2013.
Article in English | MEDLINE | ID: mdl-23472112

ABSTRACT

According to traditional murine bioassay methodology, prions must be serially passaged within a new host before a stable phenotype, and therefore a strain, can be assigned. Prions often transmit with difficulty from one species to another; a property termed the transmission barrier. Transgenic mouse lines that over express prion protein (PrP) genes of different species can circumvent the transmission barrier but serial passages may still be required, particularly if unknown strains are encountered. Here we sought to investigate whether protein misfolding cyclic amplification (PMCA), an in-vitro method of PrP(Sc) replication, could be used to replace serial passage of VRQ/VRQ classical scrapie isolates undergoing strain typing in ovine transgenic tg338 mice. Two classical scrapie field isolates that do not readily transmit to wild-type mice underwent bioassay in tg338 mice pre- and post- PMCA and the phenotype of disease in inoculated mice was compared. For one of the sources investigated, the PMCA product gave rise to the same disease phenotypes in tg338 mice as traditional bioassay, as indicated by lesion profile, IHC analysis and Western blot, whilst the second source produced phenotypic characteristics which were not identical with those that arose through traditional bioassay. These data show that differences in the efficiency of PMCA as a strain-typing tool may vary between ovine classical scrapie isolates and therefore suggest that the ability of PMCA to replace serial passage of classical scrapie in tg338 mice may depend on the strain present in the initial source.


Subject(s)
Biological Assay/methods , PrPSc Proteins/classification , Scrapie/metabolism , Animals , Genotype , Immunoenzyme Techniques , Immunohistochemistry , Mice , Mice, Transgenic , Molecular Typing , Phenotype , PrPSc Proteins/genetics , Protein Folding , Protein Isoforms , Scrapie/genetics , Sheep , Transgenes
4.
Vet Rec ; 172(3): 70, 2013 Jan 19.
Article in English | MEDLINE | ID: mdl-23249774

ABSTRACT

Bovine spongiform encephalopathy (BSE) is a prion disease of cattle which was first observed in Great Britain (GB) in 1986. Throughout the subsequent BSE epidemic, cases identified by passive surveillance have shown consistent histopathological, immunohistochemical, biochemical and biological properties. However, since the start of active surveillance in 2001, across Europe and elsewhere, approximately 67 cases with different biochemical characteristics have been identified by Western blotting (WB). These cases fall into two categories; 'H-type' (H-BSE) or 'L-type' (L-BSE), based on the relatively heavy (H-BSE) or light (L-BSE) mass of the unglycosylated band of the prion protein, as compared with WB against that obtained from classical BSE (C-BSE) cases. Here we report the detection and confirmation of the first four L-BSE cases by active surveillance in GB, two of which were born after the reinforced feed ban of 1996 (BARB cases). These four L-BSE cases were found in relatively old cattle (age range; 11-21 years old) and the carcases did not enter the human food chain or animal feed chains.


Subject(s)
Encephalopathy, Bovine Spongiform/epidemiology , PrPSc Proteins/genetics , Sentinel Surveillance/veterinary , Age Factors , Animals , Blotting, Western/veterinary , Cattle , Encephalopathy, Bovine Spongiform/pathology , Immunohistochemistry/veterinary , PrPSc Proteins/classification , United Kingdom/epidemiology
5.
Vet Res ; 43: 77, 2012 Nov 01.
Article in English | MEDLINE | ID: mdl-23116457

ABSTRACT

Mouse bioassay can be readily employed for strain typing of naturally occurring transmissible spongiform encephalopathy cases. Classical scrapie strains have been characterised historically based on the established methodology of assessing incubation period of disease and the distribution of disease-specific vacuolation across the brain following strain stabilisation in a given mouse line. More recent research has shown that additional methods could be used to characterise strains and thereby expand the definition of strain "phenotype". Here we present the phenotypic characteristics of classical scrapie strains isolated from 24 UK ovine field cases through the wild-type mouse bioassay. PrPSc immunohistochemistry (IHC), paraffin embedded tissue blots (PET-blot) and Western blotting approaches were used to determine the neuroanatomical distribution and molecular profile of PrPSc associated with each strain, in conjunction with traditional methodologies. Results revealed three strains isolated through each mouse line, including a previously unidentified strain. Moreover IHC and PET-blot methodologies were effective in characterising the strain-associated types and neuroanatomical locations of PrPSc. The use of Western blotting as a parameter to define classical scrapie strains was limited. These data provide a comprehensive description of classical scrapie strain phenotypes on isolation through the mouse bioassay that can provide a reference for further scrapie strain identification.


Subject(s)
Biological Assay/methods , PrPSc Proteins/classification , Scrapie/metabolism , Animals , Blotting, Western/methods , Brain/metabolism , Immunohistochemistry/methods , Mice , Mice, Inbred C57BL , Molecular Typing/methods , Paraffin Embedding/methods , PrPSc Proteins/genetics , Scrapie/genetics , Sheep
6.
BMC Vet Res ; 8: 42, 2012 Apr 02.
Article in English | MEDLINE | ID: mdl-22472560

ABSTRACT

BACKGROUND: The United States control program for classical ovine scrapie is based in part on the finding that infection is typically spread through exposure to shed placentas from infected ewes. Transmission from goats to sheep is less well described. A suitable rodent model for examining the effect of caprine scrapie isolates in the ovine host will be useful in the ovine scrapie eradication effort. In this study, we describe the incubation time, brain lesion profile, glycoform pattern and PrPSc distribution patterns in a well characterized transgenic mouse line (Tg338) expressing the ovine VRQ prion allele, following inoculation with brain from scrapie infected goats. RESULTS: First passage incubation times of caprine tissue in Tg338 ovinized mice varied widely but second passage intervals were shorter and consistent. Vacuolation profiles, glycoform patterns and paraffin-embedded tissue blots from terminally ill second passage mice derived from sheep or goat inocula were similar. Proteinase K digestion products of murine tissue were slightly smaller than the original ruminant inocula, a finding consistent with passage of several ovine strains in previous reports. CONCLUSIONS: These findings demonstrate that Tg338 mice propagate prions of caprine origin and provide a suitable baseline for examination of samples identified in the expanded US caprine scrapie surveillance program.


Subject(s)
Goat Diseases/genetics , Goat Diseases/transmission , PrPSc Proteins/classification , PrPSc Proteins/metabolism , Scrapie/genetics , Scrapie/transmission , Animals , Biological Assay , Goats , Mice , Mice, Transgenic , PrPSc Proteins/pathogenicity , Scrapie/classification , Sheep , United States
7.
Folia Neuropathol ; 50(1): 20-45, 2012.
Article in English | MEDLINE | ID: mdl-22505361

ABSTRACT

Human prion diseases are a unique group of transmissible neurodegenerative diseases that occur as sporadic, familial or acquired disorders and show a wide range of phenotypic variation. The latter has been attributed to the existence of distinct strains of the agent or prion, and the genetic background of the host, namely the primary sequence of the gene encoding the prion protein, which is the site of mutations and polymorphisms. The characterization of distinct isoforms of the abnormal prion protein in the brain of affected patients, which has been shown to correlate with the disease phenotype, has recently led to the concept of molecular strain typing, in which the different prion protein isoforms or "types", possibly enciphering the strain variability in their conformation, may serve as surrogate markers for individual prion strains. In sporadic Creutzfeldt-Jakob disease, the most common human prion disease, there are at least six distinct clinico-pathological disease phenotypes that largely correlate at a molecular level with two prion protein types with distinctive physicochemical properties and the genotype at the methionine/valine polymorphic codon 129 in the prion protein gene. Recent results of transmission studies indicate that five prion strains with distinctive biological properties can be isolated from these six disease variants. It has also been shown that about a third of sporadic cases show a mixed phenotype and the co-occurrence of prion protein types. The origin of prion strains and their co-occurrence as well as the mechanisms underlying the strain-specific neuronal targeting remain largely unexplained and their understanding constitute, together with the development of successful therapies and more sensitive and specific clinical biomarkers, the major challenges that this disease poses for the future.


Subject(s)
Prion Diseases/classification , Prion Diseases/diagnosis , Prion Diseases/genetics , Humans , Pathology, Molecular , PrPSc Proteins/classification , PrPSc Proteins/genetics
8.
Emerg Infect Dis ; 17(1): 55-63, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21192855

ABSTRACT

The agent that causes bovine spongiform encephalopathy (BSE) may be infecting small ruminants, which could have serious implications for human health. To distinguish BSE from scrapie and to examine the molecular characteristics of the protease-resistant prion protein (PrP(res)), we used a specifically designed Western blot method to test isolates from 648 sheep and 53 goats. During 2002-2009, classical non-Nor98 transmissible spongiform encephalopathy had been confirmed among ≈1.7 million small ruminants in France. Five sheep and 2 goats that showed a PrP(res) pattern consistent with BSE, or with the CH1641 experimental scrapie source, were identified. Later, bioassays confirmed infection by the BSE agent in 1 of the 2 goats. Western blot testing of the 6 other isolates showed an additional C-terminally cleaved PrP(res) product, with an unglycosylated band at ≈14 kDa, similar to that found in the CH1641 experimental scrapie isolate and different from the BSE isolate.


Subject(s)
Encephalopathy, Bovine Spongiform/diagnosis , Goat Diseases/diagnosis , PrPSc Proteins/classification , Prion Diseases/veterinary , Scrapie/diagnosis , Sheep Diseases/diagnosis , Animals , Blotting, Western/methods , Cattle , Encephalopathy, Bovine Spongiform/metabolism , Endopeptidases , France , Goat Diseases/metabolism , Goats , Humans , Molecular Typing , PrPSc Proteins/genetics , PrPSc Proteins/isolation & purification , PrPSc Proteins/metabolism , Prion Diseases/diagnosis , Prion Diseases/metabolism , Scrapie/metabolism , Sheep , Sheep Diseases/metabolism
9.
Brain Pathol ; 21(3): 298-307, 2011 May.
Article in English | MEDLINE | ID: mdl-21029243

ABSTRACT

The vacuolation, neuronal loss and gliosis that characterize human prion disease pathology are accompanied by the accumulation of an aggregated, insoluble and protease-resistant form (termed PrP(Sc)) of the host-encoded normal cellular prion protein (PrP(C)). In variant Creutzfeldt-Jakob disease the frontal cortex and cerebellum exhibit intense vacuolation and the accumulation of PrP(Sc) in the form of amyloid plaques and plaque-like structures. In contrast the posterior thalamus is characterized by intense gliosis and neuronal loss, but PrP(Sc) plaques are rare and vacuolation is patchy. We have used sucrose density gradient centrifugation coupled with conformation dependent immunoassay to examine the biochemical properties of the PrP(Sc) that accumulates in these different brain regions. The results show a greater degree of PrP(Sc) polydisperal in thalamus compared with frontal cortex or cerebellum, including a subpopulation PrP(Sc) molecules in the thalamus that have sedimentation properties resembling those of PrP(C). Much effort has focused on identifying aspects of PrP(Sc) biochemistry that distinguish between different forms of human prion disease and contribute to differential diagnosis. Here we show that PrP(Sc) sedimentation properties, which can depend on aggregation state, correlate with, and may underlie the distinct neurodegenerative processes occurring in different regions of the variant Creutzfeldt-Jakob disease brain.


Subject(s)
Creutzfeldt-Jakob Syndrome/pathology , PrPC Proteins/metabolism , PrPSc Proteins/metabolism , Thalamus/pathology , Case-Control Studies , Centrifugation, Density Gradient , Cerebellum/metabolism , Cerebellum/pathology , Creutzfeldt-Jakob Syndrome/genetics , Creutzfeldt-Jakob Syndrome/metabolism , Frontal Lobe/metabolism , Frontal Lobe/pathology , Genetic Variation , Humans , PrPC Proteins/classification , PrPC Proteins/isolation & purification , PrPSc Proteins/classification , PrPSc Proteins/isolation & purification , Protein Conformation , Protein Isoforms , Reference Values , Thalamus/metabolism , Tissue Distribution
10.
Acta Neuropathol ; 121(1): 91-112, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21107851

ABSTRACT

Human prion diseases are rare neurodegenerative disorders related to prion protein misfolding that can occur as sporadic, familial or acquired forms. In comparison to other more common neurodegenerative disorders, prion diseases show a wider range of phenotypic variation and largely transmit to experimental animals, a feature that led to the isolation and characterization of different strains of the transmissible agent or prion with distinct biological properties. Biochemically distinct PrP(Sc) types have been demonstrated which differ in their size after proteinase cleavage, glycosylation pattern, and possibly other features related to their conformation. These PrP(Sc) types, possibly enciphering the prion strains, together with the naturally occurring polymorphism at codon 129 in the prion protein gene have a major influence on the disease phenotype. In the sporadic form, the most common but perhaps least understood form of human prion disease, there are at least six major combinations of codon 129 genotype and prion protein isotype, which are significantly related to distinctive clinical-pathological subgroups of the disease. In this review, we provide an update on the current knowledge and classification of the disease subtypes of the sporadic human prion diseases as defined by molecular features and pathological changes. Furthermore, we discuss the molecular basis of phenotypic variability taking into account the results of recent transmission studies that shed light on the extent of prion strain variation in humans.


Subject(s)
Phenotype , PrPC Proteins/genetics , PrPSc Proteins/genetics , Prion Diseases , Animals , Codon/genetics , Diagnosis, Differential , Disease Models, Animal , Forecasting/methods , Humans , Polymorphism, Genetic/genetics , PrPC Proteins/chemistry , PrPC Proteins/physiology , PrPSc Proteins/chemistry , PrPSc Proteins/classification , Prion Diseases/genetics , Prion Diseases/metabolism , Prion Diseases/pathology
11.
Proc Natl Acad Sci U S A ; 107(26): 12005-10, 2010 Jun 29.
Article in English | MEDLINE | ID: mdl-20547859

ABSTRACT

The biological determinants of the phenotypic variation in sporadic Creutzfeldt-Jakob disease (sCJD) are unknown. To categorize sCJD cases, the prion protein (PrP) codon 129 genotype and the biochemical characteristics of the disease-associated form of PrP (PrP(Sc)) can be combined to form six subgroups (MM1, MM2, MV1, MV2, VV1, and VV2). This classification largely correlates with the known variation in the clinical and pathological features of sCJD, with the MM1 and MV1 cases representing the "classic" phenotype of sCJD. To address how this classification relates to different strains of sCJD we have inoculated each subgroup of sCJD to a panel of mice expressing different forms of the human PRNP gene (129MM, 129VV, and 129MV). We have established that all subtypes are transmissible to at least one genotype of mouse, and both agent and host factors determine transmission efficiency and the form of PrP(Sc) deposited in the brain. Moreover, we have identified four distinct strains of sCJD using our in vivo strain typing panel.


Subject(s)
Creutzfeldt-Jakob Syndrome/genetics , Creutzfeldt-Jakob Syndrome/transmission , PrPSc Proteins/classification , PrPSc Proteins/genetics , Animals , Brain/metabolism , Brain/pathology , Codon/genetics , Creutzfeldt-Jakob Syndrome/metabolism , Creutzfeldt-Jakob Syndrome/pathology , Genetic Variation , Genotype , Humans , Immunohistochemistry , Mice , Mice, Transgenic , Phenotype , PrPSc Proteins/metabolism , PrPSc Proteins/pathogenicity , Recombinant Proteins/classification , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Vacuoles/pathology
12.
J Vet Diagn Invest ; 22(3): 408-11, 2010 May.
Article in English | MEDLINE | ID: mdl-20453215

ABSTRACT

Scrapie, a transmissible spongiform encephalopathy of sheep and goats, exists in most small ruminant-producing countries of the world. A novel form of this disease was recently recognized and is known by various names, including Nor98, Nor98-like, and atypical scrapie. Differing from classic scrapie in epidemiology, histopathology, and biochemical characteristics, atypical scrapie cases have been identified throughout Europe and in the United States. Enhanced scrapie surveillance efforts recently identified 3 cases of atypical scrapie in Canada.


Subject(s)
PrPSc Proteins/pathogenicity , Scrapie/epidemiology , Animals , Blotting, Western , Canada/epidemiology , Codon/genetics , Goat Diseases/epidemiology , Goat Diseases/virology , Goats , Immunoblotting/methods , PrPSc Proteins/classification , PrPSc Proteins/genetics , Prion Diseases/diagnosis , Prion Diseases/epidemiology , Prion Diseases/veterinary , Prion Diseases/virology , Prions/genetics , Prions/pathogenicity , Sheep , Sheep Diseases/epidemiology , Sheep Diseases/virology , United States
13.
J Neuropathol Exp Neurol ; 69(5): 483-97, 2010 May.
Article in English | MEDLINE | ID: mdl-20418778

ABSTRACT

It is currently believed that primary transmission of classical scrapie to wild-type mice is inefficient and characterized by low attack rates and variable incubation periods and lesion profiles. Consequently, strain characterization of classical scrapie in these mice relies on subpassage. The aim of this study was to perform a retrospective analysis of lesion profiles and immunohistochemistry patterns after transmission of a large number of classical scrapie sources to wild-type mice and to investigate trends that might be used to characterize the agent without subpassaging. Scrapie field cases (n = 31) collected from individual farms between 1996 and 1999 were inoculated into RIII, C57BL, and VM mice and profiled using standard methodology and analyzed by immunohistochemistry. Using cluster analysis to resultant lesion profiles produced groups of similar lesion profiles in RIII and C57BL mice. We observed correlations between lesion profile clusters and the ovine prion protein (PrP) genotype. Immunohistochemistry indicated donor-mediated trends in the PrP pattern. These results indicate that ovine PrP genotype is a factor that is linked to both the lesion profile and the pattern of PrP deposition on primary transmission of classical scrapie to wild-type mice.


Subject(s)
Brain/metabolism , Brain/pathology , Immunohistochemistry/methods , PrPSc Proteins , Scrapie , Animals , Cell Count/methods , Cluster Analysis , Disease Models, Animal , Genotype , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Tissue Proteins/metabolism , Neurons/metabolism , PrPSc Proteins/classification , PrPSc Proteins/genetics , PrPSc Proteins/metabolism , Receptors, IgG/genetics , Retrospective Studies , Scrapie/genetics , Scrapie/pathology , Scrapie/transmission , Sheep
14.
Science ; 327(5967): 869-72, 2010 Feb 12.
Article in English | MEDLINE | ID: mdl-20044542

ABSTRACT

Prions are infectious proteins consisting mainly of PrP(Sc), a beta sheet-rich conformer of the normal host protein PrP(C), and occur in different strains. Strain identity is thought to be encoded by PrP(Sc) conformation. We found that biologically cloned prion populations gradually became heterogeneous by accumulating "mutants," and selective pressures resulted in the emergence of different mutants as major constituents of the evolving population. Thus, when transferred from brain to cultured cells, "cell-adapted" prions outcompeted their "brain-adapted" counterparts, and the opposite occurred when prions were returned from cells to brain. Similarly, the inhibitor swainsonine selected for a resistant substrain, whereas, in its absence, the susceptible substrain outgrew its resistant counterpart. Prions, albeit devoid of a nucleic acid genome, are thus subject to mutation and selective amplification.


Subject(s)
Brain Chemistry , Evolution, Molecular , PrPSc Proteins , Prions/physiology , Prions/pathogenicity , Animals , Cell Line , Cell Line, Tumor , Culture Media , Culture Media, Conditioned , Mice , Mice, Inbred C57BL , Mutation , PrPSc Proteins/chemistry , PrPSc Proteins/classification , PrPSc Proteins/pathogenicity , Prion Diseases , Prions/chemistry , Prions/classification , Protein Conformation , Swainsonine/pharmacology
15.
Arch Virol ; 154(12): 1929-32, 2009.
Article in English | MEDLINE | ID: mdl-19876594

ABSTRACT

We performed a transmission study using mice to clarify the characteristics of the most recent case of scrapie in Japan. The mice that were inoculated with the brain homogenate from a scrapie-affected sheep developed progressive neurological disease, and one of the scrapie-affected mice showed unique clinical signs during primary transmission. This mouse developed obesity, polydipsia, and polyuria. In contrast, the other affected mice exhibited weight loss and hypokinesia. In subsequent passages, the mice showed distinct characteristic scrapie phenotypes. This finding may prove that different prion strains coexist in a naturally affected sheep with scrapie.


Subject(s)
PrPSc Proteins , Scrapie , Sheep Diseases , Animals , Brain/metabolism , Female , Japan , Mice , Mice, Inbred ICR , Obesity/physiopathology , PrPSc Proteins/classification , PrPSc Proteins/metabolism , PrPSc Proteins/pathogenicity , Prions/classification , Prions/metabolism , Prions/pathogenicity , Scrapie/metabolism , Scrapie/physiopathology , Scrapie/transmission , Sheep , Sheep Diseases/metabolism , Sheep Diseases/transmission , Species Specificity , Weight Loss
16.
Acta Neuropathol ; 118(5): 659-71, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19718500

ABSTRACT

Six subtypes of sporadic Creutzfeldt-Jakob disease with distinctive clinico-pathological features have been identified largely based on two types of the abnormal prion protein, PrP(Sc), and the methionine (M)/valine (V) polymorphic codon 129 of the prion protein. The existence of affected subjects showing mixed phenotypic features and concurrent PrP(Sc) types has been reported but with inconsistencies among studies in both results and their interpretation. The issue currently complicates diagnosis and classification of cases and also has implications for disease pathogenesis. To explore the issue in depth, we carried out a systematic regional study in a large series of 225 cases. PrP(Sc) types 1 and 2 concurrence was detected in 35% of cases and was higher in MM than in MV or VV subjects. The deposition of either type 1 or 2, when concurrent, was not random and always characterized by the coexistence of phenotypic features previously described in the pure subtypes. PrP(Sc) type 1 accumulation and related pathology predominated in MM and MV cases, while the type 2 phenotype prevailed in VVs. Neuropathological examination best identified the mixed types 1 and 2 features in MMs and most MVs, and also uniquely revealed the co-occurrence of pathological variants sharing PrP(Sc) type 2. In contrast, molecular typing best detected the concurrent PrP(Sc) types in VV subjects and MV cases with kuru plaques. The present data provide an updated disease classification and are of importance for future epidemiologic and transmission studies aimed to identify etiology and extent of strain variation in sporadic Creutzfeldt-Jakob disease.


Subject(s)
Creutzfeldt-Jakob Syndrome/classification , Creutzfeldt-Jakob Syndrome/epidemiology , Phenotype , PrPSc Proteins/classification , PrPSc Proteins/metabolism , Aged , Aged, 80 and over , Brain/metabolism , Brain/pathology , Creutzfeldt-Jakob Syndrome/pathology , Creutzfeldt-Jakob Syndrome/physiopathology , DNA Mutational Analysis/methods , Female , Humans , Incidence , Male , Methionine/genetics , Middle Aged , Neurologic Examination/methods , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , PrPSc Proteins/genetics , Retrospective Studies , Valine/genetics
17.
Biomed Environ Sci ; 22(2): 151-6, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19618693

ABSTRACT

OBJECTIVE: To establish a stable PrP(Sc) panel from brain tissues of experimental hamsters infected with scrapie agent 263K for evaluating diagnostic techniques of human and animals' prion diseases. METHODS: Thirty brain tissue samples from hamsters intracerebrally infected with scrapie strain 263K and another 30 samples from normal hamsters were selected to prepare 10%, 1%, and 0.5% brain homogenates, which were aliquoted into stocks. PrP(Sc) in each brain homogenate was determined by proteinase K digestions followed by Western blot assay and partially by immunohistochemistry. Stability and glycoforms of PrP(Sc) were repeatedly detected by PrP(Sc)-specific Western blots in half a year and 3 years later. RESULTS: PrP(Sc) signals were observed in all 10% brain homogenates of infected hamsters. Twenty out of 30 stocks and 19 out of 30 stocks were PrP(Sc) positive in 1% and 0.5% brain homogenatesof infected hamsters, respectively. Twenty-seven out of 30 stocks presented three positive bands in 10% brain homogenates, whereas none of 1% and 0.5% homogenates contained 3 bands. The detection of PrP(Sc)-specific signals stored in half a year and 3 years later demonstrated that the ratio of PrP(Sc) positive samples and glycoforms was almost unchanged. All normal hamsters' brain homogenates were PrP(Sc) negative. CONCLUSION: A PrP(Sc) panel of prion disease can be established, which displays reliably stable PrP(Sc)-specific signals and glycoforms.


Subject(s)
PrPSc Proteins/classification , Animals , Brain , Cricetinae , Immunohistochemistry , Male , Scrapie
18.
J Neurovirol ; 14(5): 352-61, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18989813

ABSTRACT

The molecular and structural features of infectious agents that cause CJD, scrapie and BSE remain controversial. A major impediment for agent resolution is the very long and expensive animal assays of infectivity. It is crucial to develop a rapid and broadly applicable cell culture assay to titer and compare different TSE agent strains. Because we found GT1 hypothalamic cells, unlike neuroblastoma N2a clones, were highly susceptible to a variety of TSE agents, and could stably produce high agent titers for >1 year, we studied the progressive display of abnormal prion protein (PrP-res) in GT1 cells following exposure to serially diluted 22L scrapie brain homogenates; PrP-res was used as a surrogate, but non-quantitative marker of GT1 infection. Even as early as the first cell split after 22L exposure, GT1 cells produced their own PrP-res bands that were clearly different than brain bands. Plots from passages 3-7 showed a good discrimination of 3 fold differences in titer over a range of >2 logs, with the same endpoint sensitivity (2 x 10(8) LD(50)/gm) as animal assays. Interestingly, the rapid production of de novo PrP-res suggested that GT1 PrP-res might be induced by interaction with an early-intermediate form of a particle that was not fully infectious. The GT1 assay here was also invaluable for rapidly identifying cell cultures with variant titers, even after detergent lysis. Additionally, in-situ PrP amyloid staining provided an independent measure of the minimum infectious dose per cell. Standardized GT1 assays can be used for direct comparison of different agent strains, and will facilitate the rapid isolation of essential agent components.


Subject(s)
Biological Assay/methods , Culture Techniques/methods , PrPSc Proteins/pathogenicity , Prion Diseases/metabolism , Animals , Biological Assay/standards , Cell Line , Mice , PrPSc Proteins/classification , PrPSc Proteins/isolation & purification , PrPSc Proteins/metabolism , Prion Diseases/pathology , Prions/metabolism , Scrapie/metabolism , Sheep
19.
J Gen Virol ; 89(Pt 10): 2642-2650, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18796735

ABSTRACT

Native mammalian prions exist in self-propagating strains that exhibit distinctive clinical, pathological and biochemical characteristics. Prion strain diversity is associated with variations in PrP(Sc) conformation, but it remains unknown precisely which physical properties of the PrP(Sc) molecules are required to encipher mammalian prion strain phenotypes. In this study, we subjected prion-infected brain homogenates derived from three different hamster scrapie strains to either (i) proteinase K digestion or (ii) sonication, and inoculated the modified samples into normal hamsters. The results show that the strain-specific clinical features and neuropathological profiles of inoculated animals were not affected by either treatment. Similarly, the strain-dependent biochemical characteristics of the PrP(Sc) molecules (including electrophoretic mobility, glycoform composition, conformational stability and susceptibility to protease digestion) in infected animals were unaffected by either proteolysis or sonication of the original inocula. These results indicate that the infectious strain properties of native prions do not appear to be altered by PrP(Sc) disaggregation, and that maintenance of such properties does not require the N-domain (approximately residues 23-90) of the protease-resistant PrP(Sc) molecules or protease-sensitive PrP(Sc) molecules.


Subject(s)
Endopeptidase K/metabolism , PrPSc Proteins , Prions , Scrapie , Animals , Brain/metabolism , Brain/pathology , Cricetinae , Female , Mesocricetus , Phenotype , PrPSc Proteins/chemistry , PrPSc Proteins/classification , PrPSc Proteins/metabolism , Prions/chemistry , Prions/classification , Prions/metabolism , Protein Conformation , Protein Denaturation , Scrapie/metabolism , Scrapie/pathology , Scrapie/transmission , Sonication
20.
J Virol ; 82(22): 11197-207, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18768980

ABSTRACT

A more complete assessment of ovine prion strain diversity will be achieved by complementing biological strain typing in conventional and ovine PrP transgenic mice with a biochemical analysis of the resultant PrPSc. This will provide a correlation between ovine prion strain phenotype and the molecular nature of different PrP conformers associated with particular prion strains. Here, we have compared the molecular and transmission characteristics of ovine ARQ/ARQ and VRQ/VRQ scrapie isolates following primary passage in tg338 (VRQ) and tg59 (ARQ) ovine PrP transgenic mice and the conventional mouse lines C57BL/6 (Prnp(a)), RIII (Prnp(a)), and VM (Prnp(b)). Our data show that these different genotypes of scrapie isolates display similar incubation periods of >350 days in conventional and tg59 mice. Facilitated transmission of sheep scrapie isolates occurred in tg338 mice, with incubation times reduced to 64 days for VRQ/VRQ inocula and to

Subject(s)
PrPSc Proteins/classification , PrPSc Proteins/pathogenicity , Scrapie/transmission , Animals , Blotting, Western , Brain/pathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , PrPSc Proteins/immunology , PrPSc Proteins/metabolism , Sheep , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...